Tetrabuthylammonium

Tetrabuthylammonium

SCHEMBL1836121

CCCC[N+](CCCC)(CCCC)CCCC.NC(Cc1ccccc1)C(=O)O

nearest known ligand 0.67

Full drug profile on Sugi Atlas →

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SLC7A5 Q01650 6/20 0.67
ALPI P09923 1/20 0.67
PKM P14618 1/20 0.67
PTGS1 P23219 1/20 0.67
XIAP P98170 1/20 0.67
SLC1A3 P43003 2/20 0.50
SLC1A2 P43004 2/20 0.50
SLC1A1 P43005 2/20 0.50
CSNK1E P49674 1/20 0.49
CNR2 P34972 2/20 0.48
LTA4H P09960 2/20 0.48
NOS3 P29474 1/20 0.47
NOS1 P29475 1/20 0.47
NOS2 P35228 1/20 0.47
SLC15A1 P46059 1/20 0.46
HIF1A Q16665 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tetrabuthylammonium SCHEMBL1836124 1.00 SLC7A5 (0.67) SLC7A5ALPIPKMPTGS1XIAP
Tetrabuthylammonium SCHEMBL28215335 0.98 SLC7A5 (0.65) SLC7A5ALPIPKMPTGS1XIAP
Tetrabuthylammonium SCHEMBL28215334 0.98 SLC7A5 (0.65) SLC7A5ALPIPKMPTGS1XIAP
Tetradecane SCHEMBL21002171 0.91 SLC7A5 (0.76) SLC7A5ALPIPKMPTGS1XIAP
Tetrabuthylammonium SCHEMBL1836122 0.88 ALPI (0.50) SLC7A5ALPIPKMPTGS1XIAP
Tetrabuthylammonium SCHEMBL15610028 0.88 SLC7A5 (0.69) SLC7A5ALPIPKMPTGS1XIAP
Tetrabuthylammonium SCHEMBL15610029 0.88 SLC7A5 (0.69) SLC7A5ALPIPKMPTGS1XIAP
Dl-Phenylalanine SCHEMBL27802522 0.86 SLC7A5 (0.69) SLC7A5ALPIPKMPTGS1XIAP
Dl-Phenylalanine SCHEMBL28782921 0.85 SLC7A5 (0.67) SLC7A5ALPIPKMPTGS1XIAP
Myristyl Alcohol SCHEMBL28460476 0.85 SLC7A5 (0.67) SLC7A5ALPIPKMPTGS1XIAP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2322515-B1 A process for the preparation of an N-carboxy amino acid anhydride or an amino acid carbamate JSR CORP (JP) 2016-04-20 EP disclosed
US-8748650-B2 Method for production of N-carboxy amino acid anhydride and amino acid carbamate compound JSR CORPORATION (JP) 2014-06-10 US disclosed
US-20110152561-A1 METHOD FOR PRODUCTION OF N-CARBOXY AMINO ACID ANHYDRIDE AND AMINO ACID CARBAMATE COMPOUND JSR CORPORATION (JP) 2011-06-23 US disclosed
EP-2322515-A1 N-CARBOXY AMINO ACID ANHYDRIDE AND AMINO ACID CARBAMATE COMPOUND PRODUCTION METHOD JSR Corporation (JP) 2011-05-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110152561-A1 METHOD FOR PRODUCTION OF N-CARBOXY AMINO ACID ANHYDRIDE AND AMINO ACID CARBAMATE COMPOUND CA7, CPS1, DNPEP SLC7A5 124/4885ALPI 851/4885PKM 4211/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.